Immune Thrombocytopenia: Waiting for the Other Shoe to Drop
Recorded On: 08/14/2019
Immune thrombocytopenia (ITP) is an autoimmune disease that attacks the body’s platelets. It can have a newly diagnosed and persistent component and can occur in both children and adults. This presentation will discuss newly diagnosed and persistent ITP, diagnosis and treatment for children and adults, and long-term effects for patients with persistent ITP, including psychosocial and financial issues. A case example will follow a patient from diagnosis through various treatments over a 20-year span. At the conclusion of this presentation, the infusion nurse should be able to understand the importance of his or her role in administering IV medications as well as how their interactions affect the patient both short- and long-term.
Learning Outcomes: At the end of this presentation, the participant will be able to:
• Define immune thrombocytopenia and differentiate between newly diagnosed and persistent disease
• Describe 3 treatments for immune thrombocytopenia
• Discuss ways health care workers can be sensitive to patients with life altering diseases and provide support to them
Theresa Thrower, BSN, RN, CRNI®, OCN®
Home Health Case Manager, Kaiser Permanente
Theresa has been a nurse for 42 years in various fields with a primary focus in home Infusion and home health. For the last 22 years she has worked specifically with chronically ill patients as well as patients who have been diagnosed with immune thrombocytopenia.
CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: August 14, 2022
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
INS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.